320 related articles for article (PubMed ID: 11859115)
1. Tracking the immunoregulatory mechanisms active during allograft tolerance.
Sánchez-Fueyo A; Weber M; Domenig C; Strom TB; Zheng XX
J Immunol; 2002 Mar; 168(5):2274-81. PubMed ID: 11859115
[TBL] [Abstract][Full Text] [Related]
2. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
[TBL] [Abstract][Full Text] [Related]
3. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
Kingsley CI; Karim M; Bushell AR; Wood KJ
J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.
Gregori S; Casorati M; Amuchastegui S; Smiroldo S; Davalli AM; Adorini L
J Immunol; 2001 Aug; 167(4):1945-53. PubMed ID: 11489974
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
6. Anergic T cells generated in vitro suppress rejection response to islet allografts.
Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
[TBL] [Abstract][Full Text] [Related]
7. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
[TBL] [Abstract][Full Text] [Related]
8. Cytokines affecting CD4
Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ
Transpl Immunol; 2017 Aug; 43-44():33-41. PubMed ID: 28652007
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
10. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment.
Tran HM; Nickerson PW; Restifo AC; Ivis-Woodward MA; Patel A; Allen RD; Strom TB; O'Connell PJ
J Immunol; 1997 Sep; 159(5):2232-9. PubMed ID: 9278311
[TBL] [Abstract][Full Text] [Related]
11. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
[TBL] [Abstract][Full Text] [Related]
12. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.
Hara M; Kingsley CI; Niimi M; Read S; Turvey SE; Bushell AR; Morris PJ; Powrie F; Wood KJ
J Immunol; 2001 Mar; 166(6):3789-96. PubMed ID: 11238621
[TBL] [Abstract][Full Text] [Related]
13. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts.
Truong W; Plester JC; Hancock WW; Merani S; Murphy TL; Murphy KM; Kaye J; Anderson CC; Shapiro AM
Am J Transplant; 2007 Dec; 7(12):2663-74. PubMed ID: 17983390
[TBL] [Abstract][Full Text] [Related]
14. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic islet xenograft tolerance after short-term costimulation blockade is associated with increased CD4+ T cell apoptosis but not immune deviation.
Lehnert AM; Yi S; Burgess JS; O'Connell PJ
Transplantation; 2000 Mar; 69(6):1176-85. PubMed ID: 10762224
[TBL] [Abstract][Full Text] [Related]
16. Th1 to Th2 immune deviation facilitates, but does not cause, islet allograft tolerance in mice.
Zhang D; Sanchez-Fueyo A; Kawamoto K; Alexopoulos SP; Zhang W; Zheng XX
Cytokine; 2010 Sep; 51(3):311-9. PubMed ID: 20598563
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
18. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
[TBL] [Abstract][Full Text] [Related]
20. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
